Embryo Technologies Management
A special issue of Reproductive Medicine (ISSN 2673-3897).
Deadline for manuscript submissions: closed (31 December 2020) | Viewed by 13006
Interests: gamete and embryo cryopreservation; in vitro culture; micromanipulation; quality management; comparative embryo biology; reproductive physiology
Interests: embryo technologies; cryopreservation; micromanipulation; quality control
Progress in clinical in vitro fertilization (IVF) outcomes has improved appreciably over the last decade, based in part on the efficient application of assisted reproductive technologies (ARTs) and the practical experience of laboratorians and clinicians. Today’s reproductive biologists are challenged with managing hundreds of factors that ultimately influence the production of viable blastocysts capable of producing single and healthy term live births. Their responsibility is to institute quality control practices and assurance measures that safeguard the viability and identity of fresh and cryopreserved gametes and embryos while optimizing oocyte retrieval, fertilization, embryo culture, developmental monitoring and testing, embryo transfer, vitrification, and cryostorage procedures and policies. The overall purpose of this Issue is to assemble a collection of experimental studies, practical guidelines, clinical experiences, and commentaries or short reviews expressing improvements in the IVF laboratory.
We encourage skilled reproductive biologists, scientists, and clinicians to submit manuscripts that share their practical experiences and positive contributions that have influenced clinical outcomes or liability safeguards in the best interest of patients.
Dr. Mitchel C. Schiewe
Dr. Melanie R. Freeman
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Reproductive Medicine is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
assisted reproductive technologies
witnessingpreimplantation genetic testing